Titlebook: Biopatent Law: Patent Strategies and Patent Management; Andreas Hübel,Thilo Schmelcher,Ulrich Storz Book 2012 Ulrich Storz 2012 Biopharmac

摇曳

encyclopedia

2192-9904 ed how market exclusivity can be extended as long as possible, which is particularly important for biopharmaceutical drugs, which create high R&D costs..978-3-642-24845-0978-3-642-24846-7Series ISSN 2192-9904 Series E-ISSN 2192-9912

judicial

外来

说笑

Book 2012, like supplementary protection certificates and data exclusivity. Here, strategies are discussed how market exclusivity can be extended as long as possible, which is particularly important for biopharmaceutical drugs, which create high R&D costs..

控制

https://doi.org/10.1007/978-3-662-43205-1e an influence on each other. Even though these perspectives are at first hand seen as independent, typically a claimant will also become a respondent. Also the portfolio situations may change and so—up to a certain point in time—an IPR portfolio may still be shaped to same extent.

Absenteeism

Laser Speckle and Related Phenomenatent lifecycle management strategies, which encompass the strategic filing of subsequent patent applications by the applicant, may help to extend the duration under in which a biopharmaceutic product can be sold under exclusivity.

表否定

Patent Lifecycle Management, Supplementary Protection Certificates and Data Exclusivity in Biopharmtent lifecycle management strategies, which encompass the strategic filing of subsequent patent applications by the applicant, may help to extend the duration under in which a biopharmaceutic product can be sold under exclusivity.

antiandrogen

男生戴手铐

6楼